Martin Desaga

Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

Gregg W. Stone, Michel E. Bertrand, Jeffrey W. Moses et al. · JAMA · 2007 · 302 citations

Medicine, Cardiology, Internal Medicine +16

One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study

Peter Ruygrok, Martin Desaga, Franck Van Den Branden et al. · EuroIntervention · 2007 · 54 citations

Medicine, Cardiology, Surgery +14

Argatroban for elective percutaneous coronary intervention: The ARG-E04 multi-center study

Lothar Rössig, Sabine Genth‐Zotz, Matthias Rau et al. · International Journal of Cardiology · 2010 · 38 citations

Medicine, Cardiology, Surgery +14

Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI)

M. Santini, Maurizio Russo, G. L. Botto et al. · EP Europace · 2008 · 31 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Systemic exposure of everolimus after stent implantation: A pharmacokinetic study

Marcus Wiemer, Ashok Seth, Praveen Chandra et al. · American Heart Journal · 2008 · 21 citations

Medicine, Pharmacokinetics, Pharmacology +13